SolasCure
PITCH
Our proprietary technology leverages biomimicry and evidence-based medicine to develop treatments for patients with chronic wounds
LATEST INVESTMENT
#Healthtech
08.2021
£15M
BRAIN Biotech AG & Seneca Partners
PITCH
Our proprietary technology leverages biomimicry and evidence-based medicine to develop treatments for patients with chronic wounds
LATEST INVESTMENT
£15M
BRAIN Biotech AG & Seneca Partners